Pharma Days®
MassBio’s Pharma Days® are unparalleled opportunities to connect top biopharma companies with emerging technologies and entrepreneurs during a single day of activities, including business development meetings and an R&D-focused event.
MassBio’s flagship partnering events, Pharma Days®, are designed to meet your organization’s strategic external innovation needs through:
| Partnering Meetings: | Up to 25 strategically sourced one-on-one meetings between your organization and academics, entrepreneurs, or biotechs aligned with your target areas of interest. |
| R&D Strategy Information Session: | Your organization’s overview of its R&D pipeline, partnering capabilities and expertise, and target therapeutic/partnering areas through keynotes, panels, and Q&A presentation options. |
| Networking Reception: | An informal networking reception with MassBio’s innovation ecosystem and your organization’s leadership team. |
Academics, Entrepreneurs, or Biotechs
If you are looking to explore potential collaboration opportunities through one-on-one meetings with leading biopharmaceutical companies, visit the upcoming events webpage for our next Pharma Day.
Past Pharma Days:
R&D Events
Spinning out of MassBio’s Pharma Days, R&D Days enable MassBio’s extended network to participate in flexible open information sessions led by business development & licensing teams from established biopharmaceutical companies to learn about the latest insights on R&D strategy, target therapeutic areas, and partnering capabilities. R&D Days close with a networking reception for continued conversations with the host company.
Leverage MassBio’s ecosystem to grow visibility for your organization’s R&D strategy:
| R&D Strategy Information Session: | Overview of your company, R&D strategy, and pipeline. |
| Networking Reception: | An informal networking reception with MassBio’s innovation ecosystem. |
| Session Space: | Pre- or post-session space in the MassBioHub for one-on-one meetings. |
Since 2022, MassBio has facilitated three R&D Days to connect emerging entrepreneurs and established biopharmaceutical companies:
